AUTL · Healthcare · $516M
After-hours $1.96+1.23%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“AUCATZYL 매출이 전 분기 2,620만 달러에서 4,570만 달러로 74% 급증했고, 최근 네 분기 매출도 2,100만→2,400만→2,6”
In the company's words · 2026 2분기 earnings call